UNICK FIX-A-FORM AND PRINTERS | BERYL DRUGS | UNICK FIX-A-FORM AND PRINTERS/ BERYL DRUGS |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 26.7 | 14.9 | 179.2% | View Chart |
P/BV | x | 1.1 | 2.2 | 50.3% | View Chart |
Dividend Yield | % | 0.0 | 0.0 | - |
UNICK FIX-A-FORM AND PRINTERS BERYL DRUGS |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
UNICK FIX-A-FORM AND PRINTERS Mar-23 |
BERYL DRUGS Mar-23 |
UNICK FIX-A-FORM AND PRINTERS/ BERYL DRUGS |
5-Yr Chart Click to enlarge
|
||
High | Rs | 59 | 18 | 328.1% | |
Low | Rs | 32 | 8 | 420.0% | |
Sales per share (Unadj.) | Rs | 120.5 | 53.0 | 227.3% | |
Earnings per share (Unadj.) | Rs | 4.1 | 1.5 | 270.2% | |
Cash flow per share (Unadj.) | Rs | 11.2 | 3.1 | 360.0% | |
Dividends per share (Unadj.) | Rs | 0 | 0 | - | |
Avg Dividend yield | % | 0 | 0 | - | |
Book value per share (Unadj.) | Rs | 53.9 | 15.9 | 338.8% | |
Shares outstanding (eoy) | m | 5.49 | 5.07 | 108.3% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 0.4 | 0.2 | 156.0% | |
Avg P/E ratio | x | 11.1 | 8.4 | 131.2% | |
P/CF ratio (eoy) | x | 4.0 | 4.1 | 98.6% | |
Price / Book Value ratio | x | 0.8 | 0.8 | 104.7% | |
Dividend payout | % | 0 | 0 | - | |
Avg Mkt Cap | Rs m | 248 | 65 | 384.0% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 90 | 15 | 604.3% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 662 | 269 | 246.1% | |
Other income | Rs m | 5 | 3 | 183.8% | |
Total revenues | Rs m | 667 | 272 | 245.5% | |
Gross profit | Rs m | 88 | 20 | 441.7% | |
Depreciation | Rs m | 39 | 8 | 481.2% | |
Interest | Rs m | 24 | 5 | 510.1% | |
Profit before tax | Rs m | 30 | 10 | 303.8% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 7 | 2 | 342.7% | |
Profit after tax | Rs m | 22 | 8 | 292.6% | |
Gross profit margin | % | 13.3 | 7.4 | 179.5% | |
Effective tax rate | % | 25.0 | 22.1 | 112.9% | |
Net profit margin | % | 3.4 | 2.8 | 118.9% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 301 | 104 | 289.1% | |
Current liabilities | Rs m | 287 | 64 | 446.7% | |
Net working cap to sales | % | 2.1 | 14.8 | 14.3% | |
Current ratio | x | 1.0 | 1.6 | 64.7% | |
Inventory Days | Days | 4 | 14 | 27.3% | |
Debtors Days | Days | 72,349,839 | 937 | 7,723,986.9% | |
Net fixed assets | Rs m | 402 | 71 | 568.2% | |
Share capital | Rs m | 55 | 51 | 107.7% | |
"Free" reserves | Rs m | 241 | 30 | 810.9% | |
Net worth | Rs m | 296 | 81 | 366.9% | |
Long term debt | Rs m | 89 | 27 | 326.3% | |
Total assets | Rs m | 705 | 175 | 403.6% | |
Interest coverage | x | 2.3 | 3.1 | 72.6% | |
Debt to equity ratio | x | 0.3 | 0.3 | 88.9% | |
Sales to assets ratio | x | 0.9 | 1.5 | 61.0% | |
Return on assets | % | 6.6 | 7.1 | 92.9% | |
Return on equity | % | 7.6 | 9.5 | 79.8% | |
Return on capital | % | 14.0 | 13.4 | 103.8% | |
Exports to sales | % | 0 | 0 | - | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | NA | NA | - | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 0 | 0 | - | |
Fx outflow | Rs m | 0 | 0 | - | |
Net fx | Rs m | 0 | 0 | - |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 44 | 25 | 176.1% | |
From Investments | Rs m | -27 | -13 | 207.5% | |
From Financial Activity | Rs m | -16 | -12 | 139.7% | |
Net Cashflow | Rs m | 0 | 0 | 291.7% |
Indian Promoters | % | 71.6 | 26.4 | 271.3% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 0.5 | 0.0 | - | |
FIIs | % | 0.0 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 28.4 | 73.6 | 38.6% | |
Shareholders | 1,622 | 7,257 | 22.4% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare UNICK FIX-A-FORM AND PRINTERS With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | UNICK FIX-A-FORM AND PRINTERS | BERYL DRUGS | S&P BSE TECK |
---|---|---|---|
1-Day | -0.08% | -0.09% | -0.82% |
1-Month | 15.95% | 19.66% | -0.88% |
1-Year | 51.73% | 176.49% | 30.40% |
3-Year CAGR | 29.08% | 82.59% | 10.52% |
5-Year CAGR | 20.68% | 38.13% | 15.15% |
* Compound Annual Growth Rate
Here are more details on the UNICK FIX-A-FORM AND PRINTERS share price and the BERYL DRUGS share price.
Moving on to shareholding structures...
The promoters of UNICK FIX-A-FORM AND PRINTERS hold a 71.6% stake in the company. In case of BERYL DRUGS the stake stands at 26.4%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of UNICK FIX-A-FORM AND PRINTERS and the shareholding pattern of BERYL DRUGS.
Finally, a word on dividends...
In the most recent financial year, UNICK FIX-A-FORM AND PRINTERS paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of 0.0%.
BERYL DRUGS paid Rs 0.0, and its dividend payout ratio stood at 0.0%.
You may visit here to review the dividend history of UNICK FIX-A-FORM AND PRINTERS, and the dividend history of BERYL DRUGS.
For a sector overview, read our media sector report.
After opening the day on high, Indian share markets continued the momentum as the session progressed and ended the higher.